About ByCus
ByCus is a Healthcare company based in Hyderabad (India) founded in 2020 by Nageswara Rao Pulipati. Company that develops drug substances and products focused on patient care and medical advancements. The company has 46 employees. Its Indian entity Bycus Therapeutics Private Limited reported revenue of ₹3.98 Cr. Its focus areas include Biopharma Outsourcing and Diversified.
Company details
Bycusbio was founded in 2020 in Hyderabad, India, as a biotech company. Expertise is maintained in clone development, process development, regulatory compliance, and scale-up to commercial production. Drug substances and products are created to address metabolic disorders and oncology, with operations centered on advancing medical solutions in these areas.
- Headquarters Hyderabad, India
- Employees 46
- Founders Nageswara Rao Pulipati
- SectorsHealthcare
- Email••••••••
- Website bycusbio.com/home
- Legal Name Bycus Therapeutics Private Limited
- Date of Incorporation 23 Apr, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹3.98 Cr
FY 2025 · +66823% YoY
- Net Loss-₹1.39 Cr
FY 2025 · -35% margin
- EBITDA-₹88.9 Lakh
FY 2025 · -22% margin
- Employee Count46
Associated legal entities of ByCus
ByCus operates through Bycus Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bycus Therapeutics Private Limited CIN U73200TG2020PTC140175 | Active | 23 Apr 2020 | Hyderabad, Telangana | ₹4.0 Cr | 46 | 3 | View details |
Board of directors of Bycus Therapeutics Private Limited (ByCus)
Bycus Therapeutics Private Limited is the primary company behind ByCus. The board of Bycus Therapeutics Private Limited currently have 3 directors; the longest-serving is Nageswara Rao Pulipati, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nageswara Rao Pulipati DIN 08736762 | Director | 23 Apr 2020 | 6 yrs 6 mo | Bycus Therapeutics Private Limited |
| Nishanth Pasaru DIN 06770858 | Director | 23 Apr 2020 | 6 yrs 6 mo | Bycus Therapeutics Private Limited |
| Lavanya Sunkara DIN 06434012 | Director | 23 Apr 2020 | 6 yrs 6 mo | Bycus Therapeutics Private Limited |
People of ByCus
1 people are tracked at ByCus (1 in leadership); the tracked headcount is 46.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CSO | Leadership |
Complete people profiles for ByCus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of ByCus
Figures of Bycus Therapeutics Private Limited, the primary company behind ByCus, for FY 2025. Revenue was ₹3.98 Cr (+66823% year on year). Net loss was -₹1.39 Cr (-35% margin). EBITDA was -₹88.9 Lakh (-22% margin). Revenue has grown at a compounded annual rate of +162% over three years.
- ₹3.98 CrRevenue · FY 2025 · +66823% YoY
- -₹1.39 CrNet loss · -35% margin
- -₹88.9 LakhEBITDA · -22% margin
- ₹23.3 LakhPaid-up capital
- 46Employees (provident fund records)
- +162%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Bycus Therapeutics Private Limited are on its company page.
Detailed financial statements for ByCus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ByCus (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ByCus
ByCus was founded in 2020.
ByCus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
ByCus has 46 employees.
The primary company behind ByCus, Bycus Therapeutics Private Limited, reported revenue of ₹3.98 Cr for FY 2025, up 66823% year on year.
Bycusbio was founded in 2020 in Hyderabad, India, as a biotech company. Expertise is maintained in clone development, process development, regulatory compliance, and scale-up to commercial production. Drug substances and products are created to address metabolic disorders and oncology, with operations centered on advancing medical solutions in these areas.
ByCus operates through Bycus Therapeutics Private Limited.
The legal entities of ByCus currently have 3 directors, including Nageswara Rao Pulipati, Nishanth Pasaru, Lavanya Sunkara.